On 11th September 2026, Indo National Limited (NSE: NIPPOBATRY, BSE: 504058) formally notified the stock exchanges regarding an additional investment of ₹25,01,968 in Medcuore Medical Solutions Private Limited (MMSPL). The company acquired 178 equity shares at a valuation price of ₹14,056 per share based on an independent valuation report dated 21st August 2026. This transaction represents a 0.41% primary equity stake subscription on a fully diluted basis, successfully raising Indo National’s total controlling shareholding in MMSPL to 62.28%. Executed entirely through cash consideration, the acquisition does not constitute a related party transaction and is projected for complete operational integration by FY 2027-28.

This strategic equity expansion directly aligns with Indo National’s broader diversification roadmap aimed at expanding its footprint into high-growth, technology-enabled consumer and industrial sectors. Target entity Medcuore Medical Solutions Private Limited operates in the manufacturing, distribution, and service provision of specialized Air Monitoring Systems and Air Purifiers. MMSPL has demonstrated remarkable revenue acceleration in recent years, scaling its top-line turnover from ₹47.68 Lakh in FY 2023-24 and ₹35.41 Lakh in FY 2024-25 to ₹145.60 Lakh (₹1.456 Crore) in FY 2025-26. By deepening its stake in MMSPL, Indo National intends to capitalize on rising demand for environmental safety technologies, generate new non-core revenue streams, and enhance overall group profitability.

Indo National Limited, widely recognized for its iconic consumer brand ‘Nippo’, is a premier Indian manufacturer and distributor of dry-cell batteries, torchlights, LED lighting products, and electrical appliances. In 2025 and 2026, the company actively pursued brand transformation and business expansion, notably launching its premium home solutions vertical ‘Nippo Airvue’ with a target to achieve ₹100 Crore in revenues by FY 2029-30. Despite facing persistent macro headwinds in its legacy dry-cell battery business due to market shift toward rechargeable devices, Indo National maintains robust distribution capabilities across urban and rural India. On the governance front, the company recently announced the resignation of its Chief Sales Officer, Binu Sekhar, effective 1st September 2026, alongside declaring a final dividend of ₹3.75 per equity share for FY 2025-26.

From a financial perspective, Indo National Limited reported a consolidated revenue from operations of ₹115.85 Crore (₹1,158.46 Lakh) for the first quarter of FY 2026-27 (ended 30th June 2026), reflecting a sequential uptick from the ₹109 Crore registered in Q4 FY 2025-26. The company successfully executed an operational turnaround during Q1 FY 2027, achieving a consolidated net profit of ₹2.01 Crore (₹201 Lakh), compared to a net loss of ₹20.91 Crore in the preceding quarter (Q4 FY 2025-26) and a net loss of ₹7.84 Crore in Q3 FY 2025-26. For the full fiscal year FY 2025-26, the firm recorded total revenues of ₹460 Crore (₹4.60 Billion). Prominent institutional investors holding significant stakes in the company include renowned Indian financial institutions and key domestic mutual funds, maintaining steady backing as management navigates its strategic pivot into wellness and air-purification technologies.